Mark C. Korpics

Mark C. Korpics

Radiation Oncology

1850 Silver Cross Blvd. Carolyn J. Czerkies Pavilion
New Lenox, IL 60451

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Hybrid Computer Vision Model to Predict Lung Cancer in Diverse Populations.

Hybrid Computer Vision Model to Predict Lung Cancer in Diverse Populations.

Journal: JCO clinical cancer informatics

Published: March 19, 2026

A Preliminary Study on Deep Learning-Based Plan Quality Prediction in Gamma Knife Radiosurgery for Brain Metastases.

A Preliminary Study on Deep Learning-Based Plan Quality Prediction in Gamma Knife Radiosurgery for Brain Metastases.

Journal: Cancers

Published: August 18, 2025

Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis.

Limited survival benefit in patients diagnosed with glioblastoma post-2016: a SEER population based registry analysis.

Journal: Journal of cancer research and clinical oncology

Published: December 19, 2024

The Patterns of Failure and Prognostic Impact of Tumor Location in Patients Undergoing Reirradiation for Glioblastoma.

The Patterns of Failure and Prognostic Impact of Tumor Location in Patients Undergoing Reirradiation for Glioblastoma.

Journal: Cureus

Published: September 06, 2024

Online correction of intrafraction motion during volumetric modulated arc therapy for prostate radiotherapy using fiducial-based kV imaging: A cohort study quantifying the frequency of shifts and analysis of men at highest risk.

Online correction of intrafraction motion during volumetric modulated arc therapy for prostate radiotherapy using fiducial-based kV imaging: A cohort study quantifying the frequency of shifts and analysis of men at highest risk.

Journal: Journal of applied clinical medical physics

Published: July 28, 2024

Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.

Safety of combined ablative radiotherapy and immune checkpoint inhibitors in three phase I trials.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 03, 2024

Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials.

Combined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition for Liver Metastases: Safety and Outcomes in a Pooled Analysis of 3 Phase 1 Trials.

Journal: International journal of radiation oncology, biology, physics

Published: August 15, 2023

Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC.

Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC.

Journal: Clinical lung cancer

Published: June 19, 2022

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.

Partial tumor irradiation plus pembrolizumab in treating large advanced solid tumor metastases.

Journal: The Journal of clinical investigation

Published: May 30, 2022

Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.

Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.

Journal: International journal of radiation oncology, biology, physics

Published: March 15, 2022

Linear accelerator-based stereotactic radiosurgery for glossopharyngeal neuralgia is safe and effective - Report of two cases.

Linear accelerator-based stereotactic radiosurgery for glossopharyngeal neuralgia is safe and effective - Report of two cases.

Journal: Journal of radiosurgery and SBRT

Published: March 02, 2022

Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.

Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.

Journal: Head & neck

Published: October 10, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026